Utilizing data obtained from COPD patients and a mouse model of lung specific NKG2D ligand expression, we have shown that the activation of the NKG2D receptor is a potentially important contributor to lung inflammation and tissue destruction in COPD [3]. This evidence concerns the gene KLRK1 and chronic obstructive pulmonary disease.